Multivariate Analysis and Machine Learning Model Risk Prediction of Recurrent Pain After PLIF Surgery for Degenerative Lumbar Spine Disease At Long-term Follow-up
1 other identifier
observational
452
1 country
1
Brief Summary
The study was a clinical retrospective study designed to investigate risk factors for long-term recurrent pain after PLIF in patients with lumbar degenerative disease and to improve patient outcomes
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 20, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 25, 2024
CompletedFirst Submitted
Initial submission to the registry
September 28, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 28, 2024
CompletedFirst Posted
Study publicly available on registry
October 2, 2024
CompletedOctober 2, 2024
September 1, 2024
5 days
September 28, 2024
October 1, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
SAS(Pain rating scale)
The visual analogue scale (VAS) was employed to determine the patient's perception of lower back pain or lower limb pain prior to surgery, as well as 12-18 months after surgery. (0-10 scale, with 0 being painless and 10 being the most painful)
12-18 months after surgery
Study Arms (2)
Rehabilitation Group
Rehabilitation Group (n = 268): mild/non pain group with VAS\<3 at 12-18 months after PLIF。The study was retrospective and did not design an intervention
Recurrent pain group
Recurrent pain group (n = 184): recurrent pain group with VAS≥3 at 12-18 months after PLIF
Interventions
The study was retrospective and did not design an intervention
Eligibility Criteria
This study retrospectively reviewed 452 patients suffering from degenerative lumbar spinedisorders in our institute between January 2019 and February 2023. The patients were separated into Recurrent pain group and Rehabilitation Group. Recurrent pain group (n = 268): mild/non pain group with VAS\<3 at 12-18 months after PLIF;Rehabilitation Group (n = 184): recurrent pain group with VAS≥3 at 12-18 months after PLIF.
You may qualify if:
- confirmed diagnosis of lumbar degenerative disease (spinal stenosis, disc herniation with lumbar instability, and lumbar spondylolisthesis), with no significant symptomatic relief after conservative treatment for more than 3 months, and in need of surgical intervention;
- lumbar spinal fusion surgical treatment with PLIF;
- grouping based on the presence or absence of a lumbar or limb pain with VAS ≥3 at the 12-18 month postoperative follow-up;
- observational indicators including individual factors, surgical factors, spine-pelvis sagittal balance parameters, and paravertebral muscle parameters.
You may not qualify if:
- (1) those with a history of lumbar spine trauma, inflammation, tumor, or surgery; (2) those with congenital or acquired severe lumbar vertebral deformity; (3) those with severe neurological dysfunction; (4) those with incomplete baseline and follow-up data.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hao Liulead
Study Sites (1)
Medical record system and imaging system of the First Affiliated Hospital of Suzhou University
Suzhou, Jiangsu, 215006, China
Biospecimen
Biological samples were not designed for this study
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Orthopedic surgeon, First Affiliated Hospital of Suzhou University, Jiangsu Province, China
Study Record Dates
First Submitted
September 28, 2024
First Posted
October 2, 2024
Study Start
September 20, 2024
Primary Completion
September 25, 2024
Study Completion
September 28, 2024
Last Updated
October 2, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will share
Before January 1,2025;in the form of paper.The original data of the trial will be uploaded to Genome Sequence Archive (GSA) (ngdc.cncb.ac.cn)